Mankind Pharma reports 62% rise in Q4 consolidated net profit

16 May 2024 Evaluate

Mankind Pharma has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 61.63% rise in its net profit at Rs 454.17 crore for the quarter under review as compared to Rs 280.99 crore for the same quarter in the previous year. Total income of the company increased by 16.82% at Rs 2,236.54 crore for Q4FY24 as compared Rs 1,914.58 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 62.27% rise in its net profit at Rs 476.59 crore for fourth quarter ended March 31, 2024 as compared to Rs 293.70 crore for the same quarter in the previous year. Total income of the company increased by 20.62% at Rs 2,533.23 crore for Q4FY24 as compared Rs 2100.18 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 46.08% rise in its net profit at Rs 1,823.41 crore as compared to Rs 1,248.26 crore for the previous year. Total income of the company increased by 14.98% at Rs 9,531.45 crore for year under review as compared to Rs 8,289.94 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 48.26% rise in its net profit at Rs 1,941.77 crore as compared to Rs 1,309.68 crore for the previous year. Total income of the company increased by 19.57% at Rs 10,615.63 crore for year under review as compared to Rs 8,878.00 crore for year ended March 31, 2023.


Mankind Pharma Share Price

2803.45 -86.00 (-2.98%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.